Opthea Limited (ASX:OPT)
Australia
· Delayed Price · Currency is AUD 0.600
-0.005 (-0.83%)
At close: Mar 14, 2025
Opthea Market Cap
Opthea has a market cap or net worth of 738.77 million as of March 9, 2026. Its market cap has increased by 61.54% in one year.
Market Cap
738.77M
Enterprise Value
885.55M
Revenue
-20.12K
Ranking
n/a
PE Ratio
2.59
Stock Price
0.60
Market Cap Chart
Since May 13, 1996, Opthea's market cap has increased from 39.30M to 738.77M, an increase of 1,779.68%. That is a compound annual growth rate of 10.70%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immutep | 582.12M |
| Clinuvel Pharmaceuticals | 510.04M |
| Racura Oncology | 446.99M |
| Clarity Pharmaceuticals | 1.33B |
| PYC Therapeutics | 1.46B |
| Neuren Pharmaceuticals | 1.56B |
| Dimerix | 243.16M |
| Orthocell | 240.11M |